GeoVax Labs (GOVX) News Today $0.76 +0.03 (+4.02%) As of 07/18/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GOVX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period GeoVax Labs Inc. (NASDAQ:GOVX) Given Average Recommendation of "Buy" by AnalystsJuly 19 at 2:17 AM | americanbankingnews.comGeoVax Highlights Growing Urgency for Diversified Mpox Vaccine Supply as Global Outbreaks ExpandJuly 16 at 10:07 PM | finance.yahoo.comGeoVax Labs (NASDAQ:GOVX) Upgraded by Wall Street Zen to "Hold" RatingJuly 15, 2025 | americanbankingnews.comGeoVax Labs, Inc. (GOVX) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comRoth Capital Has Strong Estimate for GeoVax Labs Q3 EarningsJuly 11, 2025 | americanbankingnews.comGeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health ThreatJuly 3, 2025 | finance.yahoo.comGeoVax Responds to Growing Mpox Threat With Expedited EU Pathway and Platform Aligned to U.S. Biodefense ObjectivesJuly 2, 2025 | finance.yahoo.comGOVX - Geovax Labs Inc Dividends - MorningstarJuly 2, 2025 | morningstar.comMGeoVax to Raise Approximately $6 Million of Gross Proceeds in Public OfferingJuly 1, 2025 | finance.yahoo.comGeoVax Announces Issuance of Patent Covering Novel Vaccine Construct for Preventing Malaria Infection - NasdaqJune 27, 2025 | nasdaq.comGeoVax Comments on FDA Approval of Keytruda (R) in Head and Neck Cancer, Underscoring Potential for Gedeptin (R) Combination Therapy - NasdaqJune 26, 2025 | nasdaq.comGeoVax Announces Issuance of Patent Covering Novel Vaccine Construct for Preventing Malaria InfectionJune 25, 2025 | theglobeandmail.comGeoVax Comments on FDA Approval of Keytruda(R) in Head and Neck Cancer, Underscoring Potential for Gedeptin(R) Combination TherapyJune 24, 2025 | finance.yahoo.comGeoVax Highlights Positive Immune Response Results From GEO-CM04S1 in CLL Patients at the European Hematology Association 2025 MeetingJune 17, 2025 | finance.yahoo.comGeoVax Receives Favorable European Regulatory Guidance Supporting Streamlined Development Pathway for GEO-MVAJune 16, 2025 | finance.yahoo.comGeoVax to Participate in BIO International Convention 2025June 12, 2025 | finance.yahoo.comGeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health EmergencyJune 11, 2025 | finance.yahoo.comGeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone SymposiaJune 9, 2025 | finance.yahoo.comGeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical ManufacturingMay 29, 2025 | finance.yahoo.comGeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination GuidanceMay 27, 2025 | finance.yahoo.comGeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense InnovationMay 21, 2025 | finance.yahoo.comGeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine ProductionMay 6, 2025 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and Baxter International (BAX)May 5, 2025 | theglobeandmail.comGeovax highlights progress on mpox vaccine and COVID-19 trial advancementsMay 1, 2025 | msn.comGeoVax Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 1, 2025 | finance.yahoo.comGeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comGeoVax Responds to Detection of Clade I Mpox in North Carolina WastewaterApril 25, 2025 | theglobeandmail.comEQS-News: GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine CongressApril 24, 2025 | markets.businessinsider.comGeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine CongressApril 24, 2025 | finance.yahoo.comGeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC OperationsApril 22, 2025 | finance.yahoo.comEQS-News: GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC OperationsApril 22, 2025 | markets.businessinsider.comRoth MKM Reaffirms Their Buy Rating on GeoVax Labs (GOVX)April 15, 2025 | markets.businessinsider.comGeoVax Labs price target lowered to $14 from $18 at D. Boral CapitalApril 15, 2025 | markets.businessinsider.comEQS-News: GeoVax to Present Clinical Data at Upcoming April Industry EventsApril 15, 2025 | markets.businessinsider.comRFK Jr. vaccine comments bode well for GeoVax, says Roth CapitalApril 11, 2025 | markets.businessinsider.comGeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine PatentApril 9, 2025 | finance.yahoo.comDavid A. Dodd Acquires 10,000 Shares of GeoVax Labs, Inc. (NASDAQ:GOVX) StockApril 2, 2025 | insidertrades.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | msn.comRoth MKM Sticks to Their Buy Rating for GeoVax Labs (GOVX)March 29, 2025 | markets.businessinsider.comGeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comGeoVax Reports 2024 Year-End Financial Results and Provides Business UpdateMarch 27, 2025 | finance.yahoo.comEQS-News: GeoVax Reports 2024 Year-End Financial Results and Provides Business UpdateMarch 27, 2025 | markets.businessinsider.comWhat's Next: Geovax Labs's Earnings PreviewMarch 26, 2025 | benzinga.comEQS-News: GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMarch 24, 2025 | markets.businessinsider.comGeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMarch 24, 2025 | finance.yahoo.comEQS-News: GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UKMarch 12, 2025 | markets.businessinsider.comGeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UKMarch 12, 2025 | finance.yahoo.comEQS-News: GeoVax to Present at the 37th Annual Roth ConferenceMarch 11, 2025 | markets.businessinsider.comEQS-News: GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health PreparednessFebruary 24, 2025 | markets.businessinsider.comGeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health PreparednessFebruary 24, 2025 | finance.yahoo.com Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address GOVX Media Mentions By Week GOVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOVX News Sentiment▼0.410.57▲Average Medical News Sentiment GOVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOVX Articles This Week▼42▲GOVX Articles Average Week Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LTRN News Today MRSN News Today MDCX News Today PEPG News Today ACRV News Today KPTI News Today BRNS News Today ATHE News Today ELYM News Today RANI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOVX) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.